Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1975 1
1976 1
1978 2
1979 1
1980 1
1981 2
1982 1
1983 2
1984 4
1985 4
1987 2
1988 1
1990 1
1992 1
1993 2
1994 2
1995 1
1996 3
1998 5
1999 3
2000 1
2001 2
2002 2
2003 4
2004 2
2005 3
2006 1
2007 4
2008 4
2009 8
2010 8
2011 5
2012 1
2013 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

79 results
Results by year
Filters applied: . Clear all
Page 1
SNIDD special issue.
Burns HD, Frank RA, Waterhouse R. Burns HD, et al. Mol Imaging Biol. 2005 Jan-Feb;7(1):2-4. doi: 10.1007/s11307-005-0955-6. Mol Imaging Biol. 2005. PMID: 15912269 No abstract available.
In vivo studies of opiate receptors.
Frost JJ, Dannals RF, Duelfer T, Burns HD, Ravert HT, Langström B, Balasubramanian V, Wagner HN Jr. Frost JJ, et al. Among authors: burns hd. Ann Neurol. 1984;15 Suppl:S85-92. doi: 10.1002/ana.410150716. Ann Neurol. 1984. PMID: 6331283
Identification of an Orally Bioavailable, Potent, and Selective Inhibitor of GlyT1.
Blackaby WP, Lewis RT, Thomson JL, Jennings AS, Goodacre SC, Street LJ, MacLeod AM, Pike A, Wood S, Thomas S, Brown TA, Smith A, Pillai G, Almond S, Guscott MR, Burns HD, Eng W, Ryan C, Cook J, Hamill TG. Blackaby WP, et al. Among authors: burns hd. ACS Med Chem Lett. 2010 Jun 25;1(7):350-4. doi: 10.1021/ml1001085. eCollection 2010 Oct 14. ACS Med Chem Lett. 2010. PMID: 24900218 Free PMC article.
Imaging dopamine receptors in the human brain by positron tomography.
Wagner HN Jr, Burns HD, Dannals RF, Wong DF, Langstrom B, Duelfer T, Frost JJ, Ravert HT, Links JM, Rosenbloom SB, Lukas SE, Kramer AV, Kuhar MJ. Wagner HN Jr, et al. Among authors: burns hd. Science. 1983 Sep 23;221(4617):1264-6. doi: 10.1126/science.6604315. Science. 1983. PMID: 6604315
Discovery of N-{(1S,2S)-2-(3-cyanophenyl)- 3-[4-(2-[18F]fluoroethoxy)phenyl]-1-methylpropyl}- 2-methyl-2-[(5-methylpyridin-2-yl)oxy]propanamide, a cannabinoid-1 receptor positron emission tomography tracer suitable for clinical use.
Liu P, Lin LS, Hamill TG, Jewell JP, Lanza TJ Jr, Gibson RE, Krause SM, Ryan C, Eng W, Sanabria S, Tong X, Wang J, Levorse DA, Owens KA, Fong TM, Shen CP, Lao J, Kumar S, Yin W, Payack JF, Springfield SA, Hargreaves R, Burns HD, Goulet MT, Hagmann WK. Liu P, et al. Among authors: burns hd. J Med Chem. 2007 Jul 26;50(15):3427-30. doi: 10.1021/jm070131b. Epub 2007 Jul 3. J Med Chem. 2007. PMID: 17608398
79 results